Literature DB >> 36175812

Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study.

Ariel Kenig1,2, Yonatan Oster2,3, Ronit Cohen-Poradosu4, Klaris Reisenberg5, Anat Wieder-Finesod6,7, Mirit Hershman-Sarafov8, Ilana Oren9, Gabriel Weber10,11, Ron Dagan12, Gili Regev-Yochay7,13, Jacob Strahilevitz14,15.   

Abstract

In order to characterize pneumococcal endovascular infection in the post-vaccination era, a retrospective nationwide study based on the Israeli Adult IPD database was conducted. Between 2010 and 2019, 0.6% (23 cases) of IPD cases were of endovascular type, occurring mainly in males (72.3%) with underlying medical conditions (78.2%). Additional pneumococcal source (10 patients) and concomitant infections were not uncommon. Penicillin and ceftriaxone susceptibility rates were 65.2% and 91.3%, respectively; 60.9% of the isolates were not covered by the pneumococcal conjugate vaccine. 21.7% of patients died during hospitalization. In conclusion, pneumococcal endovascular infections still carry significant morbidity and mortality.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Endovascular infections; Infective endocarditis; Invasive pneumococcal disease; Streptococcus pneumoniae

Mesh:

Substances:

Year:  2022        PMID: 36175812     DOI: 10.1007/s10096-022-04500-w

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   5.103


  18 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel.

Authors:  Gili Regev-Yochay; Michal Katzir; Jacob Strahilevitz; Galia Rahav; Talya Finn; Dan Miron; Yasmin Maor; Bibiana Chazan; Yehudith Schindler; Ron Dagan
Journal:  Vaccine       Date:  2017-03-22       Impact factor: 3.641

3.  Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel.

Authors:  S Ben-Shimol; D Greenberg; N Givon-Lavi; N Elias; D Glikman; U Rubinstein; R Dagan
Journal:  Vaccine       Date:  2012-08-30       Impact factor: 3.641

4.  Risk factors for pneumococcal endocarditis.

Authors:  T J Marrie; G J Tyrrell; S R Majumdar; D T Eurich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-24       Impact factor: 3.267

5.  Review of pneumococcal endocarditis in adults in the penicillin era.

Authors:  S I Aronin; S K Mukherjee; J C West; E L Cooney
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

6.  Prognosis of Streptococcus pneumoniae endocarditis in France, a multicenter observational study (2000-2015).

Authors:  Amandine Périer; Mathieu Puyade; Matthieu Revest; Pierre Tattevin; Louis Bernard; Adrien Lemaignen; David Boutoille; Joseph Allal; France Roblot; Blandine Rammaert
Journal:  Int J Cardiol       Date:  2019-04-17       Impact factor: 4.164

7.  An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.

Authors:  Victor L Yu; Christine C C Chiou; Charles Feldman; Ake Ortqvist; Jordi Rello; Arthur J Morris; Larry M Baddour; Carlos M Luna; David R Snydman; Margaret Ip; Wen Chien Ko; M Bernadete F Chedid; Antoine Andremont; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2003-07-07       Impact factor: 9.079

8.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

9.  Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults.

Authors:  Esteban Martínez; Jose M Miró; Benito Almirante; Jose M Aguado; Pedro Fernandez-Viladrich; Manuel L Fernandez-Guerrero; Jose L Villanueva; Fernando Dronda; Alfonso Moreno-Torrico; Miguel Montejo; Pedro Llinares; Jose M Gatell
Journal:  Clin Infect Dis       Date:  2002-06-24       Impact factor: 9.079

Review 10.  Infective endocarditis.

Authors:  Thomas J Cahill; Bernard D Prendergast
Journal:  Lancet       Date:  2015-09-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.